Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 1412

The nuclear reactions that power the stars and forge the elements emerge from the interactions of the quantum mechanical particles, protons and neutrons. Explaining these processes is one of the most challenging unsolved problems in computational physics. As the mass of the colliding nuclei grows, the resources required to model them outpace even the most powerful conventional computers. Quantum computers could perform the necessary computations. However, they currently fall short of the required number of reliable and long-lived quantum bits. This research combined conventional computers and quantum computers to significantly accelerate the prospects of solving this problem.

The Impact

The researchers successfully used the hybrid computing scheme to simulate the scattering of two neutrons. This opens a path to computing nuclear reaction rates that are difficult or impossible to measure in a laboratory. These include reaction rates that play a role in astrophysics and national security. The hybrid scheme will also aid in simulating the properties of other quantum mechanical systems. For example, it could help researchers study the scattering of electrons with quantized atomic vibrations known as phonons, a process that underlies superconductivity.

Read more | >

“As long as the pharmaceutical companies quest for innovation is solely driven by intellectual property rights, they will keep failing in the war on cancer.”-Sylvie Beljanski.

Dr. Mirko Beljanski PhD, was a molecular biologist at the Pasteur Institute in Paris who investigated how environmental toxins damage DNA leading to cancer as well as natural compounds with protective anticancer properties. His research eventually led him to the discovery of two unique and powerful anticancer plant extracts: Pao pereira and Rauwolfia vomitoria.

In 1996 Dr. Beljanki’s lab was raided. His research was seized and he was locked in his lab and poisoned with an unknown chemical gas. The next day he was released from his lab and arrested. Two months later he was diagnosed with leukemia and remained under house arrest for the next two years awaiting a trial with no date until he passed away.

Read more | >

Japanese scientists are set to kick off the world’s first clinical trials of “tooth regrowth medicine” at the Kyoto University Hospital, The Mainichi reports.

Researchers from the Japanese startup Toregem Biopharma are planning to enroll patients who were born missing some or all of their teeth from birth, a condition called congenital anodontia, for the trials.

The patients will receive an antibody treatment that deactivates a protein called USAG-1, believed to stop “tooth buds,” which most people have, from developing into either baby or permanent teeth.

Read more | >

The founder of the dating app Bumble Whitney Wolfe Herd believes the future of dating will involve having your personal AI “dating concierge” talk to hundreds of other AIs to find a match.

That unabashed vision may sound familiar: it’s literally the plot of a 2017 episode of “Black Mirror,” as countless people on social have pointed out.

“You could, in the near future, be talking to your AI dating concierge,” Wolfe Herd, who stepped down as Bumble CEO in 2023 but remains involved in the company, told an audience at the Bloomberg Technology Summit on Thursday. “You could share your insecurities. There is a world where your dating concierge could go and date for you with other dating concierges.”

Read more | >

An excellent discussion of the history, strategies, and future of new funding models for science wherein we can Ensure that scientific progress can flourish by removing financial and institutional obstacles for the world’s best scientists, so that they can fully pursue their curiosity and produce…

For those who sit between science and tech, it’s hard not to notice the proliferation of new initiatives launched in the last two years, aimed at making major improvements in the life sciences especially.

While I don’t have a science background, nor any personal relationship to the space (other than knowing and liking many of the folks involved), I became interested in learning why the space changed so suddenly, particularly from a philanthropic lens. Figuring out what worked in science can help us tackle other, similarly-shaped problems in the world.

To understand what happened, I looked at examples of science-related efforts in tech over the past ten years (roughly 2011–2021). I looked for patterns that would help me extrapolate the norms and values of the time, as well as inflection points that shifted those attitudes. I also interviewed a number of people in the space to help me fill in the gaps, as well as to understand what they value and what success looks like.

Continue reading “Understanding science funding in tech, 2011−2021” | >